Cite
EPCT-05. Phase Ib study of unesbulin (PTC596) in children with newly diagnosed diffuse intrinsic pontine glioma (DIPG) and high-grade glioma (HGG): A report from the COllaborative Network for NEuro-Oncology Clinical Trials (CONNECT)
MLA
Margot A Lazow, et al. “EPCT-05. Phase Ib Study of Unesbulin (PTC596) in Children with Newly Diagnosed Diffuse Intrinsic Pontine Glioma (DIPG) and High-Grade Glioma (HGG): A Report from the COllaborative Network for NEuro-Oncology Clinical Trials (CONNECT).” Neuro-Oncology, vol. 24, June 2022, p. i36. EBSCOhost, https://doi.org/10.1093/neuonc/noac079.133.
APA
Margot A Lazow, Patricia Baxter, Joseph Stanek, Adam Lane, Diana P Rodriguez, Shiva Senthil Kumar, James L Leach, Leonie Mikael, Christine Fuller, Daniel R Boué, Christopher R Pierson, Diana Thomas, John Breneman, Joshua Palmer, Xiao-Nan Li, Ralph Salloum, David Ashley, Peter de Blank, Eugene Hwang, … Rachid Drissi. (2022). EPCT-05. Phase Ib study of unesbulin (PTC596) in children with newly diagnosed diffuse intrinsic pontine glioma (DIPG) and high-grade glioma (HGG): A report from the COllaborative Network for NEuro-Oncology Clinical Trials (CONNECT). Neuro-Oncology, 24, i36. https://doi.org/10.1093/neuonc/noac079.133
Chicago
Margot A Lazow, Patricia Baxter, Joseph Stanek, Adam Lane, Diana P Rodriguez, Shiva Senthil Kumar, James L Leach, et al. 2022. “EPCT-05. Phase Ib Study of Unesbulin (PTC596) in Children with Newly Diagnosed Diffuse Intrinsic Pontine Glioma (DIPG) and High-Grade Glioma (HGG): A Report from the COllaborative Network for NEuro-Oncology Clinical Trials (CONNECT).” Neuro-Oncology 24 (June): i36. doi:10.1093/neuonc/noac079.133.